MeSH D012393 - rosacea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Azelaic acid | Azelaic Acid |  | 2020-10-07 |  |  |
| Metronidazole | Metronidazole |  | 1984-11-06 |  |  | |
| Metronidazole | Vandazole | 2024-09-22 | 2005-05-20 |  |  | |
| Padagis | Adapalene, Benzoyl peroxide | Adapalene Benzoyl Peroxide |  | 2018-01-23 |  |  |
| Clindamycin, Benzoyl peroxide | Clindamycin Benzoyl Peroxide |  | 2012-06-26 |  |  | |
| Metronidazole | Metronidazole |  | 2019-07-02 |  |  | |
| Taro Pharmaceutical | Adapalene, Benzoyl peroxide | Adapalene Benzoyl Peroxide |  | 2018-01-24 |  |  |
| Azelaic acid | Azelaic Acid |  | 2019-08-23 |  |  | |
| Clindamycin, Benzoyl peroxide | Clindamycin Benzoyl Peroxide |  | 2017-12-15 |  |  | |
| Metronidazole | Metronidazole |  | 2006-07-18 |  |  | |
| Glenmark Pharmaceuticals | Adapalene, Benzoyl peroxide | Adapalene Benzoyl Peroxide |  | 2019-11-08 |  |  |
| Azelaic acid | Azelaic Acid |  | 2018-11-19 |  |  | |
| Clindamycin, Benzoyl peroxide | Clindamycin Benzoyl Peroxide |  | 2019-03-14 |  |  | |
| Metronidazole | Metronidazole |  | 2022-01-27 |  |  | |
| LEO Pharma | Azelaic acid | Finacea |  | 2002-12-24 |  |  |
| Mylan | Clindamycin, Benzoyl peroxide | Clindamycin Benzoyl Peroxide |  | 2009-08-11 |  |  |
| Johnson & Johnson | Metronidazole | Protostat |  | 1983-03-02 |  |  |
| Almirall | Azelaic acid | Azelex |  | 1995-09-13 |  |  |
| Lupin Research | Metronidazole | Metronidazole |  | 2017-09-12 |  |  |
| Bausch Health Companies | Clindamycin, Benzoyl peroxide | Benzaclin |  | 2000-12-21 |  |  |
| Erythromycin, Benzoyl peroxide | Benzamycin |  | 1984-10-26 |  |  | |
| Metronidazole | Metrogel |  | 1992-08-17 |  |  | |
| Metronidazole | Noritate |  | 1997-09-26 |  |  | |
| Clindamycin, Benzoyl peroxide | Onexton | 2029-06-03 | 2008-10-23 |  |  | |
| Clindamycin, Adapalene, Benzoyl peroxide | Cabtreo | 2029-06-03 | 2023-10-20 |  |  |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
82%9/11
Phase 2
59%13/22
Phase 3
59%13/22
Approved: 4Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use